Diligence memo · auto-generated · as of July 2, 2026
Akoya Biosciences, Inc.
Akoya Biosciences, Inc. has raised $34M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Akoya Biosciences, Inc. operates in Biotech / Pharma, based in Menlo Park.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Akoya Biosciences, Inc. has raised $34M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2018-09-26.
Most recent recorded round closed around 2018-09-26.
Valuation (modeled)modeled
Provath models Akoya Biosciences, Inc. at approximately $901M (range $50M–$3.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 7.8 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 85% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: Iota Biosciences, Inc., Bird Rock Bio, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.